Kalyan Nadiminti, MD¹, Kamal Kant Singh Abbi, MBBS¹, Annick Tricot^2*, Allyson Schultz^2*, Lindsay Dozeman^2*, Sarah L Mott, MS^2*, Fenghuang Zhan, MD, PhD³ and Guido J Tricot, MD, PhD⁴

¹Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA
²Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City, IA
³Division of Hematology, Oncology, and Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA
⁴Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA

Jordan Gauthier, MD, MSc^1,2*, Leona Holmberg, MD, PhD³, David Wu, MD, PhD^4*, William I. Bensinger, MD^5*, Ajay K. Gopal, MD⁶, Oliver W. Press, MD, PhD⁵, David G Maloney, MD, PhD⁷, Damian J. Green, MD⁵, Brian G. Till, MD⁵, Denys Byelykh, MD^8* and Andrei R. Shustov, MD³

¹Secteur allogreffe de cellules souches hématopoïétiques, CHRU Lille, Lille, France
²UFR Médecine, Université de Lille, Lille, France
³Clinical Research Division, Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA
⁴Department of Laboratory Medicine, University of Washington, Seattle, WA
⁵Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
⁶Fred Hutchinson Cancer Research Center/University of Washington, Seattle, WA
⁷Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁸Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA

Seema Naik, MD^*, Paul J. Shaughnessy, MD, Behyar Zoghi, MD, PhD, Jose C Cruz, MD^* and Carlos R. Bachier, MD

Texas Transplant Institute, San Antonio, TX

Chiara Cerrato^1*, Francesca Gay^1*, Maria Teresa Petrucci^2*, Pellegrino Musto², Gianluca Gaidano², Massimo Offidani², Tommasina Guglielmelli^2*, Marco Salvini^1*, Francesca Patriarca^2*, Elena Ponticelli^1*, Gianpietro Semenzato^2*, Francesco Di Raimondo², Roberto Mina^1*, Nicola Cascavilla^2*, Dina Ben Yehuda^3*, Daniela Oddolo^1*, Paolo Corradini², Lucio Catalano^2*, Paolo Di Bartolomeo^2*, Roman Hájek⁴, Andrew Spencer⁵, Mario Boccadoro, MD¹ and Antonio Palumbo¹

¹Myeloma Unit, Division of Hematology, University of Torino, Torino, Italy
²Italian Multiple Myeloma Network, GIMEMA, Italy
³Hematology Division, Hadassah Medical Center, Jerusalem, Israel
⁴Faculty of Medicine, University of Ostrava and Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic
⁵Myeloma Research Group, ACBD, Alfred Health-Monash University, Melbourne, Australia

Suzanne Lentzsch¹, Nicolas Villanueva, MD^2*, James Nguyen, BS^3*, Heather Landau, MD³, Nikoletta Lendvai, MD PhD⁴, Susanna Miao, BA^1*, Jordan M. Schecter, MD¹, Mariamne Reyna, BS^1*, Markus Y Mapara, MD, PhD¹, Robert L. Redner, MD⁵, David J Chung, MD PhD⁶, Alexander M. Lesokhin, MD⁷, Tarun Kewalramani, MD⁸, Sergio Giralt, MD⁶, Raymond L. Comenzo, MD⁹, Ola Landgren, MD, PhD⁷ and Hani Hassoun, MD⁷

¹Division of Hematology/Oncology, Columbia University, New York, NY
²Columbia University, Department of Internal Medicine, New York
³Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁴Memorial Sloan-Kettering Cancer Center, New York, NY
⁵University of Pittsburgh, Division of Hematology/Oncology, Department of Medicine, Pittsburgh, PA
⁶Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Division of Hematology-Oncology, Department of Medicine, Lahey Clinic Medical Center, Burlington, MA
⁹Division of Hematology/Oncology, John C. Davis Myeloma and Amyloid Program, Tufts Medical Center, Boston, MA

Francesco Maura, MD^1*, Anna Dodero^1*, Alessio Pellegrinelli, MD^2*, Martina Pennisi^1*, Liliana Franca Devizzi^1*, Anna Guidetti, MD¹, Cristiana Carniti, PhD^1*, Lucia Farina, MD, PhD^1*, Antonello Cabras, MD^2* and Paolo Corradini^1,3

¹Department of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
²Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
³Chair of Hematology, University of Milano, Milan, Italy

Raija Silvennoinen, MD^1,2*, Pekka Anttila, MD^3*, Marjaana Säily, MD, PhD^4*, Tuija Lundan, PhD^5*, Jouni Heiskanen, MD^6*, Timo Siitonen, MD, PhD^4*, Sakari Kakko, MD, PhD^4*, Mervi Putkonen, MD, PhD^7*, Hanna Ollikainen, MD^8*, Venla Terävä, MD^9*, Anu Partanen, MD^10*, Kirsi Launonen, MD^11*, Anu Räsänen, MD^12*, Anu Sikiö, MD^13*, Merja Suominen, MD^14*, Piotr Bazia, MD^15*, Kristiina Kananen, MD, PhD^15*, Tuomas Selander, MSc^16*, Taru Kuittinen, MD, PhD^17*, Kimmo Porkka, MD, PhD¹⁸, Kari Remes, MD, PhD^7,19* and Esa Jantunen, MD, PhD^17*

¹Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
²Kuopio University Hospital, Department of Internal Medicine, Kuopio, Finland
³Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
⁴Hematology-Oncology Unit, Oulu University Hospital, Oulu, Finland
⁵Department of Clinical Chemistry and TYKSLAB, University of Turku and Turku University Central Hospital, Turku, Finland
⁶Stem Cell Transplantation Unit, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland
⁷Hematology Unit, Turku University Central Hospital, Turku, Finland
⁸Department of Medicine, Satakunta Central Hospital, Pori, Finland
⁹Hematology Unit, Tampere University Hospital, Tampere, Finland
¹⁰Department of Medicine, Mikkeli Central Hospital, Mikkeli, Finland
¹¹Department of Medicine, Länsi-Pohja Central Hospital, Kemi, Finland
¹²Department of Medicine, Kymenlaakso Central Hospital, Kotka, Finland
¹³Department of Medicine, Central Finland Central Hospital, Jyväskylä, Finland
¹⁴Department of Medicine, Kanta-Häme Central Hospital, Hämeenlinna, Finland
¹⁵Department of Medicine, Kainuu Central Hospital, Kajaani, Finland
¹⁶Science Services Center, Kuopio University Hospital, Kuopio, Finland
¹⁷Department of Medicine, Kuopio University Hospital, Kuopio, Finland
¹⁸Hematology Research Unit Helsinki, University of Helsinki, and Helsinki University Central Hospital Comprehensive Cancer Center, Department of Hematology, Helsinki, Finland
¹⁹University of Turku, Turku, Finland

Paul J Bröckelmann, MD^1*, Horst Müller, PhD^1*, Olivier Casasnovas, MD^2*, Martin Hutchings, MD^3*, Bastian von Tresckow, MD^1*, Peter Borchmann, MD¹, Craig Moskowitz, MD⁴ and Andreas Engert, MD¹

¹Department I of Internal Medicine and German Hodgkin Study Group (GHSG), University Hospital of Cologne, Cologne, Germany
²Hematology Department, Hopital Le Bocage, CHU Dijon, Dijon, France
³Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
⁴Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Manish Sharma, M.D.¹, Parmeswaran Hari, MD, MRCP, MS², Jennifer Le-Rademacher, PhD^2*, Amrita Krishnan³, Yago Nieto, MD, PhD⁴, Cristina Gasparetto, MD⁵, Jiaxing Huang, MS^2*, Emma C. Scott, MD⁶ and Anita D'Souza, MBBS, MD⁷

¹Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
²CIBMTR (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
³City of Hope National Medical Center, Duarte, CA
⁴M.D. Anderson Cancer Center, Houston, TX
⁵Duke University Medical Center, Durham, NC
⁶Center for Hematologic Malignancies, The Knight Cancer Institute, Oregon Health and Science University and the Knight Cancer Institute, Portland, OR
⁷Froedtert Memorial Lutheran Hospital, Milwaukee, WI

Yago Nieto, M.D., Ph.D.¹, Roland Bassett, MS^2*, Paolo Anderlini, MD¹, Chitra M. Hosing, MD¹, Amin M. Alousi, MD¹, Uday R. Popat, MD¹, Borje S. Andersson, MD, PhD¹, Benigno C. Valdez, PhD¹, Elizabeth J. Shpall, MD¹, Sairah Ahmed, MD¹, Muzaffar Qazilbash, M.D.¹, Maria Guillermo^3*, Yasuhiro Oki, MD⁴, Michelle A. Fanale⁴, Fredrick B. Hagemeister, MD⁵, Bouthaina S. Dabaja, MD⁶, Chelsea C Pinnix, MD PhD^6*, Sarah A Milgrom, MD^6*, Priti Tewari, MD⁷, Richard E. Champlin, MD¹ and Roy Jones, MD, PhD^1*

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX

John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath^1*, David A Cairns^2*, Cathy Williams^3*, A Hockaday^2*, J. D. Cavenagh, MD, MRCP⁴, John A Snowden, MD, FRCP, FRCPath⁵, Christopher Parrish, MD^6*, Kwee L Yong, MBChB, PhD^7*, Jim Cavet, FRCPath^8*, Hannah Hunter⁹, Jennifer Bird^10*, Guy Pratt, MD¹¹, Sally Chown^12*, Earnest Heartin^13*, Sheila J.M. O'Connor^14*, Julia Brown, PhD^15*, Curly Morris, MD¹⁶ and Gordon Cook, MD, PhD^17,18

¹Mid-Yorkshire Hospitals NHS Trust/Univeristy of Leeds, Wakefield, England
²Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
³Centre for Clinical Haematology, Nottingham University Hospitals, Nottingham, United Kingdom
⁴Dept. of Hematology, St. Bartholomew's Hospital, London, United Kingdom
⁵Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
⁶St James's Institute of Oncology, Leeds, United Kingdom
⁷Department of Haematology, UCL Cancer Institute, London, United Kingdom
⁸The Christie NHS Foundation Trust, Manchester, United Kingdom
⁹Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
¹⁰University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
¹¹Centre for Clinical Haematology, Birmingham Heartlands Hospital, Birmingham, United Kingdom
¹²Gloucestershire Hospitals Trust, Deaprtment of Haematology, Gloucester, United Kingdom
¹³Conwy & Denbighshire NHS Trust, Department of Haematology, Bodelwyddan, United Kingdom
¹⁴HMDS, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
¹⁵Univeristy of Leeds, Clincial Trials Research Unit, Leeds, United Kingdom
¹⁶Centre for Cancer Research & Cell Biology, Queen's University of Belfast, Belfast, United Kingdom
¹⁷University of Leeds, Leeds, United Kingdom
¹⁸St James's University Hospital, Leeds, United Kingdom

Donna Reece, MD¹, Giovanni Piza Rodriguez, MD^1*, Mariela Pantoja, PhD, MSc^2*, Darrell White, MD³, Christopher P. Venner, MD⁴, Julie Stakiw, MD⁵, Michael Sebag, MD, PhD⁶, Terrance Comeau, MD⁷, Kevin Song, MD⁸, Jean Roy, MD⁹, Leonard Minuk, MD¹⁰, Jason Tay, MD, MSc^11*, Vishal Kukreti, MD¹, Suzanne Trudel, MD¹, Prica Anca, MD^1*, Rodger Tiedemann, MBChB, PhD¹, Christine Chen, MD¹ and Harminder Paul^1*

¹Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Princess Margaret Cancer Centre, Toronto, ON, Canada
³Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁴Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁵Saskatoon Cancer Center, Saskatoon, SK, Canada
⁶Division of Hematology, McGill University Health Center, McGill University, Montreal, QC, Canada
⁷Saint John Regional Hospital, St. John, NB, Canada
⁸Division of Hematology and Leukemia/BMT, University of British Columbia, Vancouver, BC, Canada
⁹Division of Hematology and Oncology, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
¹⁰London Health Sciences Centre, London, ON, Canada
¹¹Ottawa Hospital Research Institute, Ottawa, ON, Canada

Bente Arboe^1*, Kristina Fruerlund Nielsen^2*, Charlotte Madsen^3*, Rasmus Heje Thomsen^4*, Soeren Ramme Nielsen^5*, Jette Soenderskov Goerloev^1* and Peter de Nully Brown, MD PhD⁶

¹Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark
²Department of Hematology, Odense University Hospital, Odense C, Denmark
³Department of Hematology, Aarhus University Hospital, Aarhus C, Denmark
⁴Department of Hematology, Copenhagen University Hospital, Herlev, Denmark
⁵Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
⁶Department of Hematology, University Hospital of Copenhagen, Copenhagen, Denmark

Ioanna Sakellari, MD, PhD^1*, Despina Mallouri, MD^1*, Varnavas C Constantinou, MD^1*, Michail Iskas, MD^1*, Ioannis Batsis, MD^1*, Stergios Papadimitriou, MD Resident^1*, Kira Panteliadou, MD Resident^1*, Panayiotis Palladas, MD^2*, Ioannis Datseris, MD, PhD^3* and Achilles Anagnostopoulos, MD¹

¹Hematology - BMT Unit, George Papanicolaou General Hospital, Thessaloniki, Greece
²Department of Radiology, George Papanicolaou General Hospital, Thessaloniki, Greece
³Evangelismos General Hospital, Nuclear Medicine and PET/CT Department, Athens, Greece

Perrine Guillaume-Jugnot, MD^1*, Zora Marjanovic^2*, Myriam Labopin, MD^3*, Louis Terriou, MD^4*, Christophe Deligny^5*, Bruno Lioure, MD^6*, Thierry Martin^7*, Veronique Leblond, MD⁸, Gregory Pugnet^9*, Didier Blaise¹⁰, Régis Peffault de Latour, MD^1*, Ibrahim Yakoub-Agha, MD, PhD^11,12, John A Snowden, MD, FRCP, FRCPath¹³ and Dominique Farge, PhD, MD^14,15

¹Saint Louis Hospital, Paris, France
²Saint Antoine Hopital, Paris, France
³Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France
⁴Department of Internal Medicine, Hôpital HURIEZ CHRU Lille, Lille, France
⁵CHU de Martinique, Fort de France, France
⁶Department of Hematology and Oncology, CHU Hautepierre, Strasbourg, France
⁷Strasbourg University Hospitals, Strasbourg, France
⁸Department of Clinical Hematology, Pitie-Salpetriere Hospital and Pierre et Marie Curie University, Paris, France
⁹CHU Toulouse Purpan, Toulouse, France
¹⁰Department of Hematology, Institut Paoli Calmettes, Marseille, France
¹¹CHRU Lille, Lille, France
¹²SFGM-TC, Lille, France
¹³Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
¹⁴EBMT-ADWP, Paris, France
¹⁵Médecine interne et pathologie vasculaire, Hôpital Saint Louis (Assistance Publique Hôpitaux de Paris), Paris, France

Santosha A. Vardhana, MD, PhD¹, Craig H. Moskowitz, MD¹, Craig S. Sauter, MD², Matthew J Matasar, MD, MS^3*, Natasha Galasso^4*, Kaitlin M Woo, MS^5* and Zhigang Zhang, PhD^5*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY

Brian T. Hill, MD, PhD¹, Lisa A. Rybicki, MS^2*, Catherine Weber, PharmD^1*, Deepa Jagadeesh, MD, MPH¹, Aaron T. Gerds, MD, MS³, Betty K. Hamilton, MD^1,4, Hien K. Liu, MD¹, Robert M. Dean, MD¹, Ronald M. Sobecks, MD¹, Brad Pohlman, MD¹, Steven Andresen, DO^1*, Matt Kalaycio, MD¹, Brian J. Bolwell, MD¹ and Navneet S. Majhail, MD, MS⁵

¹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH
³Leukemia Program, Cleveland Clinic, Cleveland, OH
⁴Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
⁵Taussig Cancer Institute, Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Lakshmikanth Katragadda, MD¹, Lindsay McCullough, MD^2*, Yunfeng Dai, PhD^3*, Jack W Hsu, MD⁴, John W Hiemenz, MD^1*, W. Stratford May, MD, PhD¹, Christopher R. Cogle, MD¹, Maxim Norkin, MD, PhD¹, Randy A Brown, MD¹, John R. Wingard, MD⁵, Myron Chang, PhD^6* and Jan S Moreb, MD¹

¹University of Florida, Gainesville, FL
²Medicine, University of Florida, Gainesville, FL
³Biostatistics, University of Florida, Gainesville, FL
⁴Medicine/Hematology & Oncology, Univeristy of Florida, Gainesville, FL
⁵UF Shands Cancer Center, University of Florida, Gainesville, FL
⁶Department of Biostatistics, College of Medicine, University of Florida, Gainesville, FL

Laurent Garderet, MD¹, Cyrille Touzeau, MD^2*, Anne-Marie Stoppa, MD³, Denis Caillot^4*, Lionel Karlin^5*, Philippe Moreau, MD, PhD^2*, Jean Fontan^6*, Myriam Labopin, MD^7*, Emmanuelle Polge^8*, mor Seny Gueye^9*, Eric Beohou^10*, Souhila Ikhlef^11*, Zora Marjanovic^12*, Didier Blaise, MD, PhD¹³ and Mohamad Mohty, MD¹⁴

¹Hôpital Saint Antoine, Paris, France
²Nantes University Hospital, Hôtel Dieu, Nantes, France
³Institut Paoli Calmettes, Marseille, France
⁴Hôpital du Bocage, Dijon, France
⁵Service d'Hématologie, Centre Hospitalier Lyon Sud, Pierre Bénite, France
⁶Service Hematologie, CHU Besancon, Besancon, France
⁷EBMT, Acute Leukemia Working Party, Paris, France
⁸EBMT Department of Haematology, Saint Antoine Hospital, Paris, France
⁹University Hospital saint antoine, Paris, France
¹⁰Hôpital Saint-Antoine, EBMT, Acute Leukemia Working Party and Registry, Paris, France
¹¹Département d’hématologie, Hôpital Saint Antoine, Paris, France
¹²Saint Antoine Hopital, Paris, France
¹³Programme de Transplantation et Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
¹⁴Department of Hematology and Cell Therapy, Saint Antoine Hospital, Paris, France

Amine MA Bekadja, PhD, MD^*, Souad ST Talhi, MD^*, Hafida OH Ouldjeriouat, MD^*, Osmani OS Soufi, MD^*, Mohamed BM Brahimi, MD^*, Rachid Amar RB Bouhass, PhD, MD^*, Nabil Yafour, MD^* and Abdessamed AA Arabi, MD^*

HEMATOLOGY AND CELL THERAPY, UNIVERSITY ORAN/ EHU 1ST NOVEMBER, ORAN, Algeria

Aaron S Rosenberg, MD, MS¹, Ann M Brunson, BS^2*, Theresa HM Keegan, PhD, MSc^2*, Brian Jonas, MD, PhD³, Joseph Tuscano, MD⁴ and Ted Wun, MD⁵

¹Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
²University of California, Davis, Sacramento, CA
³UC Davis Comprehensive Cancer Center, Sacramento, CA
⁴University of California Davis, Sacramento, CA
⁵Division of Hematology and Oncology, University of California – Davis School of Medicine, Sacramento, CA

Yago Nieto, M.D., Ph.D.¹, Benigno C. Valdez, PhD¹, Peter F Thall, PhD^2*, Wei Wei, MS^2*, Roy Jones, MD, PhD^1*, Chitra M. Hosing, MD¹, Sairah Ahmed, MD¹, Uday R. Popat, MD¹, Elizabeth J. Shpall, MD¹, Muzaffar Qazilbash, M.D.¹, Alison M Gulbis^3*, Paolo Anderlini, MD¹, Nina Shah, MD^1*, Qaiser Bashir, MD^1*, Amin M. Alousi, MD¹, Yasuhiro Oki, MD⁴, Fredrick B. Hagemeister, MD⁵, Richard E. Champlin, MD¹ and Borje S. Andersson, MD, PhD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
³Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Siyang Leng, MD^1*, Erin Moshier, MS^2*, Douglas Tremblay, MD^1*, Noa Biran, MD³, Naman Barman, BS^1*, Sundar Jagannath, MD⁴ and Ajai Chari, MD^5,6

¹Icahn School of Medicine at Mount Sinai, New York, NY
²Mount Sinai Medical Center, New York City, NY
³John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
⁴Tisch Cancer Institute / Multiple Myeloma Program, Mount Sinai School of Medicine, New York, NY
⁵Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
⁶Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Valkal Bhatt, PharmD^1*, Michael Scordo, MD^1*, Meier Hsu, MS^2*, Antonio M. Omuro, MD^3*, Lisa DeAngelis, MD^4*, Andrew Lin, PharmD^5*, Matthew J. Matasar, MD, MS⁶, Parastoo B. Dahi, MD¹, Craig H. Moskowitz, MD⁷, Sergio A. Giralt, MD¹ and Craig S. Sauter, MD¹

¹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Neurology, Memorial Sloan Kettering, New York, NY
⁵Memorial Sloan-Kettering, New York, NY
⁶Department of Medicine, Lymphoma and Adult BMT Services, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Umberto Falcone, MD, PhD^1*, Shaheena Bashir^2*, Khalil Al-Farsi, MD^3*, Laurie Watkins^3*, C. Denise Turvey, RN^4*, Norman Franke, MD^5*, Armand Keating, MD³, Michael Crump, MD⁶ and John Kuruvilla, MD^7,8

¹Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
²2Department of Biostatistics,, Princess Margaret Cancer Centre, Toronto, Canada
³Princess Margaret Cancer Centre, Toronto, Canada
⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵Princess Margaret Cancer Center, Toronto, Canada
⁶Princess Margaret Hospital, Toronto, ON, Canada
⁷Division of Medical Oncology and Hematology, University of Toronto, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON, Canada

Gunjan L Shah, MD MS¹, Meier Hsu, MS^2*, Sean Devlin, PhD^2*, David J Chung, MD PhD¹, Hani Hassoun, MD³, Guenther Koehne, MD PhD¹, Neha S Korde, MD³, Nikoletta Lendvai, MD, PhD³, Alexander M. Lesokhin, MD³, Ola Landgren, MD, PhD³, Heather Landau, MD⁴ and Sergio A. Giralt, MD⁵

¹Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
⁵Department of Medicine, Adult Bone Marrow Transplantation Services, Memorial Sloan Kettering Cancer Center, New York, NY

Shebli Atrash^1,2, Bart Barlogie, MD, PhD², Maurizio Zangari, MD², Frits van Rhee, MD, PhD², Sarah Waheed, MD^2*, Clyde Bailey^2*, Nathan Petty, MS^2*, Christoph Heuck, MD², Gareth J Morgan, MD PhD² and Yogesh Jethava, MD^1,2*

¹Department of Hematology/Oncology, University of Arkansas for Medical Sciences, Little Rock, AR
²Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Karen Sweiss, PharmD^1*, Katie Culos, PharmD^2*, Seema Patel, PharmD^3*, Annie L. Oh, MD⁴, Damiano Rondelli, MD⁵ and Pritesh R. Patel, MB, ChB⁴

¹Department of Pharmacy Practice, University of Illinois at Chicago, Chicago
²Department of Pharmacy, Vanderbilt University, Nashville, TN
³Pharmacy, Mount Sinai Hospital, Chicago, IL
⁴Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
⁵Department of Medicine, Hematology/Oncology, University of Illinois at Chicago, Chicago, IL

Alessandro Isidori, M.D. PhD¹, Stefano Guidi^2*, Potito Rosario Scalzulli, MD^3*, Attilio Olivieri, MD⁴, Emanuele Angelucci⁵, Saveria Capria, M.D.^6*, Francesca Patriarca^7*, Barbara Castagnari, M.D.^8*, Francesco Angrilli, MD^9*, Daniele Vallisa, MD¹⁰, Gerardo Musuraca^11*, Andrea Mengarelli, MD^12*, Piero Galieni^13*, Gaudio Francesco^14*, Patrizia Tosi^15*, Pier Luigi Zinzani, MD, PhD¹⁶, Alberto Bosi², Donatella Baronciani^5*, Nicola Cascavilla, MD^3*, Barbara Guiducci^1*, Cristina Clissa, M.D.^1*, Elisa Gabucci^1*, Marco Rocchi^17*, Federica Loscocco, PhD^1* and Giuseppe Visani, M.D.^1*

¹Hematology and Stem Cell Transplant Center, AORMN Hospital, Pesaro, Italy
²Hematology and Stem Cell Transplant Center, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy
³Hematology and BMT Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
⁴Haematology Clinic, Ospedali Riuniti di Ancona, Ancona, Italy
⁵Struttura Complessa di Ematologia e Centro Trapianto Cellule Staminali Emopoietiche, Ospedale Oncologico di Riferimento Regionale “Armando Businco”, Cagliari, Italy
⁶Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Hematology, Rome, Italy
⁷Hematology and BMT Center, Santa Maria della Misericordia Hospital, Udine, Italy
⁸Hematology, S. Maria delle Croci Hospital, Ravenna, Italy
⁹Hematology and BMT Center, Spirito Santo Hospital, Pescara, Italy
¹⁰Civic Hospital of Piacenza Onc. Hem. Unit, Piacenza, Italy
¹¹Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Meldola (FC),, Meldola, Italy
¹²Hematology, Regina Elena National Cancer Institute, Rome, Italy
¹³Hematology and Cellular Therapy, Ospedale Mazzoni, Ascoli Piceno, Italy
¹⁴Division of Hematology, University of Bari, Bari, Italy
¹⁵Oncology and Hematology, Infermi Hospital, Rimini, Italy
¹⁶Institute of Hematology “L. & A. Seràgnoli”, University of Bologna, Bologna, Italy
¹⁷Institute of Biomathematics, Urbino University, Urbino, Italy

Lisa Giulino Roth, MD^1,2, Tara O'Donohue MD^1,3*, Tanya Trippett, MD^4*, Elizabeth Klein, MPH^2*, Nancy A. Kernan, MD⁵, Rachel Kobos, MD^6*, Susan Prockop, MD⁶, Andromachi Scaradavou, MD², Neerav Shukla, MD^7*, Peter G Steinherz, MD⁶, Alison J Moskowitz, MD⁸, Craig H. Moskowitz, MD⁹ and Farid Boulad, MD¹⁰

¹Pediatrics, Weill Cornell Medical College, New York, NY
²Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
³Pediatrics, Memorial Sloan Kettering Cancer Center, New York
⁴Memorial Sloan Kettering Cancer Cent., New York, NY
⁵Pediatric BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Memorial Sloan Kettering, New York
⁸Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Pediatrics - BMT, Memorial Sloan-Kettering Cancer Center, New York, NY

Michael Styler, MD¹, Pamela Ann Crilley, DO², Maneesh Jain, MD³, Kristine Ward, MD³, David Topolsky, MD⁴, David Cho, MD^5,6 and Marc Kim, MD^7*

¹Drexel Unviersity College of Medicine, Philadelphia, PA
²Div. of Hematology/Oncology, Drexel University College of Medicine/Hahnemann University Hospital, Philadelphia, PA
³Drexel University College of Medicine, Philadelphia, PA
⁴Hahnemann Univ. Hospital, Philadelphia, PA
⁵Drexel University/Hahnemann Hospital, Philadelphia, PA
⁶Drexel University / Hahnemann University Hospital, Philadelphia, PA
⁷Department of Internal Medicine, Drexel University College of Medicine, Philadelphia, PA